Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

A new vertigo relief app is in development to assist adults suffering from recurrent benign paroxysmal positional vertigo (BPPV). The app aims to guide users through repositioning maneuvers like the Epley, using animated instructions, audio cues, and gyroscope-based head-angle feedback. It is designed for both self-management and potential integration into clinical practice, offering symptom logging and recurrence tracking. This development responds to the growing demand for digital vestibular rehabilitation tools, accelerated by shifts toward telehealth during the COVID-19 pandemic.

The app is targeted primarily at adults, skewing female and older, who often face long waits for ENT or vestibular specialist care. It aims to address the challenge of performing repositioning maneuvers correctly at home, which many patients currently struggle with using static diagrams or instructions. The initial version will include a screening survey for BPPV candidacy, guided step-by-step maneuver instructions, and episode tracking features. The app will carry a disclaimer emphasizing it is not a substitute for medical advice and will prompt users to seek professional care if red-flag symptoms appear.

Development plans include a freemium model for consumers, with free basic maneuver guides and paid features such as detailed symptom history, reminders, and export options. Additionally, a B2B offering will license the app to ENT clinics, audiologists, and physiotherapists for patient home programs. Validation efforts involve running targeted ads to measure signups and maneuver completion rates, as well as pitching clinics to gauge interest in recommending the app for between-visit care.

Potential Impact on BPPV Self-Management and Clinical Care

This app could significantly improve self-treatment accuracy for BPPV, reducing relapse rates and improving patient quality of life. It also offers a scalable solution for clinics to extend care outside the office, especially amid ongoing healthcare access challenges. As digital therapeutics gain acceptance and reimbursement frameworks mature, such tools could become standard components of vestibular disorder management, potentially reducing long-term healthcare costs and patient burden.

Growing Market and Technology Enablement for Digital Vestibular Therapies

The digital vestibular rehabilitation market was valued near USD 498 million in 2024, with a projected compound annual growth rate of approximately 13.5% through 2033. Advances in smartphone sensors, particularly gyroscopes and accelerometers, now enable precise motion tracking essential for guided maneuvers. The COVID-19 pandemic accelerated telehealth adoption, creating a favorable environment for digital therapeutics targeting vestibular disorders. Currently, there are limited consumer-focused tools for BPPV self-management, representing a significant market opportunity.

Previous efforts have mainly involved clinician-led programs or static educational materials. The new app aims to bridge the gap by combining real-time motion feedback with user-friendly guidance, making home treatment safer and more effective. Validation efforts are planned to confirm user engagement and clinical acceptance before wider rollout.

“The integration of gyroscope-based feedback could improve the accuracy of self-administered maneuvers, potentially reducing relapse rates.”

— an anonymous researcher

Unconfirmed Aspects of App Validation and Clinical Integration

It is not yet clear how effectively the app will perform in real-world settings or how quickly clinics will adopt it for routine use. Validation studies are still in planning stages, and user engagement metrics remain to be established. Additionally, regulatory approval pathways and reimbursement models for such digital therapeutics are still evolving, which could influence deployment timelines.

Next Steps for Development, Testing, and Market Entry

The development team plans to launch a lightweight landing page and a guided Epley maneuver demo to gauge interest and collect user feedback. Validation efforts include pilot testing with a small cohort of patients and clinics, with results expected within the next 6-12 months. Success in these phases could lead to broader clinical trials, regulatory submissions, and eventual commercial rollout for both consumer and professional markets.

Key Questions

How does the app guide users through the maneuvers?

The app provides animated step-by-step instructions, audio cues, and uses gyroscope sensors to give real-time head-angle feedback, helping users perform maneuvers correctly at home.

Is the app safe for self-use without medical supervision?

The app includes a screening questionnaire and disclaimers emphasizing it is not a substitute for professional medical advice. Users are advised to consult a healthcare provider if they experience red-flag symptoms or severe dizziness.

Will clinics be able to recommend or license the app?

Yes, a B2B licensing model is planned, allowing ENT and vestibular clinics to incorporate the app into their patient care protocols for between-visit management.

When will the app be available to the public?

The app is still in development, with pilot testing and validation phases expected to take at least 6-12 months before wider release.

How will the app track symptoms and recurrence?

It will log dizziness episodes, triggers, and severity over time, providing users and clinicians with data to monitor progress and recurrence risks.

Source: IdeaNavigator AI